Thermo Fisher Scientific Inc.

TMO

$483.56

+39.2% (1 year change)

Avg closing price

Price range

Market Cap

$191 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$342.47 - $531.72

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

24.11x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.96 (0.2%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $191 Billion
Enterprise Value $204 Billion
Dividend Yield $0.96 (0.2%)
1 Year Return +39.4%
52-Week High $531.72
52-Week Low $342.47
Beta 0.8
Outstanding Shares 393 Million
Avg 30 Day Volume 2.15 Million

Valuation

P/E Ratio 24.11
PEG 12.26
Earnings per Share $19.90
Price to Sales Ratio 5.31
Price to Book Ratio 5.43
Revenue to Enterprise Value 5.69
EBIT to Enterprise Value 20.39
Total Debt to Enterprise Value 0.09
Debt to Equity 0.53

Profitability

Revenue $35.9 Billion
Gross Profit $18.5 Billion
EBIT $10 Billion
Net Income $7.92 Billion
Profit Margin 22.08%
Quarterly Earnings Growth (YoY) +196.6%
Return on Equity 22.6%
Return on Assets 12.02%
Return on Invested Capital 16.99%

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, the company is here to support them. Its global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

News

Procalcitonin Antibody Market Trend and Growth Opportunities by 2027| Thermo Fisher, Roche Diagnostics, bioMerieux

Procalcitonin Antibody Market Trend and Growth Opportunities by 2027| Thermo Fisher, Roche Diagnostics, bioMerieux

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain ...

OpenPR OpenPR, about 12 hours ago
Non-Radioactive Nucleic Acid Labeling Product Market Trend and Growth Opportunities by 2027| Thermo Fisher Scientific, Roche, Promega

Non-Radioactive Nucleic Acid Labeling Product Market Trend and Growth Opportunities by 2027| Thermo Fisher Scientific, Roche, Promega

In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of r...

OpenPR OpenPR, 1 day ago
In-Vitro Diagnostics Market 2021 Is Booming Across the Globe by Top Players  Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France)

In-Vitro Diagnostics Market 2021 Is Booming Across the Globe by Top Players Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France)

COVID 19 Impact on In-Vitro Diagnostics Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region Global...

Jumbo News Jumbo News, 3 days ago